News
the wholly-owned subsidiary of Pharmaniaga Bhd, has entered into a research collaboration agreement with BioNet-Asia Co Ltd, a Thai-French biotech vaccine company, for the development of a ...
Sanofi has moved ahead with plans to challenge Pfizer and MSD for a piece of the market for pneumococcal vaccines, taking a 21-valent shot licensed from SK Biosciences into phase 3 testing.
KUALA LUMPUR: Pharmaniaga Bhd expects to invest about RM100 million over the next two to three years in facilities to manufacture halal and cost-effective vaccines at its existing life science ...
Vaxcyte's new pneumococcal vaccine may only have phase 1/2 results behind it, but analysts are already predicting it could be a major competitor to rival shots from Pfizer and MSD. Just-reported ...
Read all vaccine information available from your health care professional before receiving the vaccine. If you have any questions, ask your health care professional. This vaccine is injected into ...
Pneumococcal pneumonia is a potentially serious bacterial lung disease that can disrupt your life for weeks and even land you in the hospital. Medical experts want you to know that there are steps you ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results